This protocol addresses rheumatic heart disease in patients presenting with mixed mitral valve disease — the concurrent involvement of both mitral regurgitation and mitral stenosis.
In mixed mitral valve disease, medical treatment options are narrow. Diuretic agents may represent the only pharmacological therapy available, making timely assessment of valvular severity essential.
When valvular dysfunction reaches a severe degree — especially in symptomatic patients — a surgical intervention targeting the mitral valve is indicated. The full protocol details the decision criteria, timing, and specific surgical options.